Case File №
#VI-2026-0315
Kerisite Shenzhen International
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
40 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Cagrilintide | B Good | 2 | 6.5 | 6.5 | 6.6 | 14 Jul 2025 |
| Retatrutide | D Poor | 14 | 7.1 | 3.4 | 10.0 | 25 Jun 2025 |
| Adipotide | X N/A | 1 | 6.7 | 6.7 | 6.7 | 3 Jul 2025 |
| AICAR Oral | X N/A | 1 | 8.6 | 8.6 | 8.6 | 17 Dec 2024 |
| Andarine S4 | X N/A | 1 | 7.7 | 7.7 | 7.7 | 2 Jul 2025 |
| APAA (alpha-phenylacetoacetamide) CAS 102-01-2 | X N/A | 1 | 4.1 | 4.1 | 4.1 | 2 Apr 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 4.5 | 4.5 | 4.5 | 7 May 2025 |
| Clomiphene (Clomid) Raw | X N/A | 1 | 5.8 | 5.8 | 5.8 | 11 Jun 2025 |
| Dianabol | X N/A | 1 | 6.3 | 6.3 | 6.3 | 8 Jul 2025 |
| Enclomiphene | X N/A | 1 | 6.2 | 6.2 | 6.2 | 11 Jun 2025 |
| Epithalon | X N/A | 1 | 5.0 | 5.0 | 5.0 | 2 Apr 2025 |
| EPO | X N/A | 1 | 6.3 | 6.3 | 6.3 | 24 Apr 2025 |
| Equipoise (Boldenone Undecylenate) | X N/A | 1 | 6.4 | 6.4 | 6.4 | 2 Jul 2025 |
| GHRP-2 Acetate | X N/A | 1 | 6.6 | 6.6 | 6.6 | 25 Apr 2025 |
| Halotestin (Fluoxymesterone) | X N/A | 1 | 4.6 | 4.6 | 4.6 | 7 May 2025 |
| Hexarelin | X N/A | 1 | 5.8 | 5.8 | 5.8 | 2 Apr 2025 |
| KissPeptin-10 | X N/A | 1 | 9.3 | 9.3 | 9.3 | 27 Feb 2025 |
| KPV Oral | X N/A | 1 | 5.4 | 5.4 | 5.4 | 9 Jun 2025 |
| Liraglutide | X N/A | 1 | 6.8 | 6.8 | 6.8 | 2 Apr 2025 |
| Methylamine hydrochloride CAS 593-51-1 | X N/A | 1 | 5.5 | 5.5 | 5.5 | 2 Jul 2025 |
| MT-1 | X N/A | 1 | 4.0 | 3.3 | 3.3 | 27 Feb 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 5.3 | 5.3 | 5.3 | 6 May 2025 |
| Orforglipron | X N/A | 1 | 5.1 | 5.1 | 5.1 | 24 Apr 2025 |
| Ostarine (MK-2866) | X N/A | 1 | 5.7 | 5.7 | 5.7 | 13 Jun 2025 |
| Oxymetholone (Anadrol) Raw | X N/A | 1 | 8.4 | 8.4 | 8.4 | 24 Apr 2025 |
| Pinealon | X N/A | 1 | 6.7 | 6.7 | 6.7 | 25 Apr 2025 |
| Prostamax | X N/A | 1 | 9.0 | 9.0 | 9.0 | 24 Apr 2025 |
| Proviron (Mesterolone) | X N/A | 1 | 6.7 | 6.7 | 6.7 | 3 Jul 2025 |
| PTD-DBM | X N/A | 1 | 6.2 | 6.2 | 6.2 | 28 Mar 2025 |
| Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | X N/A | 1 | 5.5 | 5.5 | 5.5 | 11 Jun 2025 |
| Semax | X N/A | 1 | 5.7 | 5.7 | 5.7 | 9 Jun 2025 |
| Sildenafil Raw | X N/A | 1 | 7.8 | 7.8 | 7.8 | 7 May 2025 |
| SLU-PP-332 | X N/A | 1 | 4.0 | 3.2 | 3.2 | 8 Jul 2025 |
| SNAP-8 | X N/A | 1 | 4.0 | 3.8 | 3.8 | 2 Apr 2025 |
| Super Shred | X N/A | 1 | 5.8 | 5.8 | 5.8 | 16 Mar 2025 |
| T4 (Levothyroxine) | X N/A | 1 | 6.4 | 6.4 | 6.4 | 7 May 2025 |
| Telmisartan | X N/A | 1 | 5.2 | 5.2 | 5.2 | 28 Mar 2025 |
| Testosterone Enanthate Raw | X N/A | 1 | 4.0 | 3.6 | 3.6 | 8 Jul 2025 |
| Trestolone Acetate (MENT) Raw | X N/A | 1 | 5.9 | 5.9 | 5.9 | 13 Jun 2025 |
| Turinabol | X N/A | 1 | 6.1 | 6.1 | 6.1 | 3 Jun 2025 |
Exhibit II
Evidence Log
45 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Andarine S4 | 8.0 A | 10mg | 10.9mg | +8.6% | 97.35% | 8pu6ek | Lab A | Public |
| 25 May 2026 | Semax | 4.0 C | 2mg | 1.8mg | -10.2% | 98.69% | r8y6my | Lab C | Public |
| 24 May 2026 | APAA (alpha-phenylacetoacetamide) CAS 102-01-2 | 6.6 A | 5g | 6.0g | +19.5% | 95.78% | jau8z1 | Lab F | Public |
| 24 May 2026 | Liraglutide | 7.7 A | 30mg | 27.0mg | -10.0% | 99.24% | h4emws | Lab D | Public |
| 24 May 2026 | Ostarine (MK-2866) | 6.4 A | 50mg | 53.3mg | +6.6% | 99.33% | hpm0ao | Lab B | Public |
| 24 May 2026 | Retatrutide | 4.7 D | 30mg | 29.5mg | 26.1mg | -11.6% | 98.63% | No Label / Silver Crimp / Clear Blue Cap | Lab E |
| 24 May 2026 | T4 (Levothyroxine) | 6.9 A | 20mg | 17.2mg | -14.2% | 97.24% | 9hkic4 | Lab B | Public |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 8.1 A | 30mg | 34.8mg | +16.1% | 97.37% | zocb1s | Lab B | Community |
| 24 May 2026 | Epithalon | 5.2 B | 15mg | 15.3mg | +2.2% | 97.98% | 9d35cm | Lab B | Community |
| 24 May 2026 | GHRP-2 Acetate | 4.2 C | 2mg | 2.5mg | +23.5% | 95.11% | vgeohj | Lab D | Community |
| 24 May 2026 | Halotestin (Fluoxymesterone) | 6.4 A | 20mg | 23.1mg | +15.3% | 98.47% | 5dszhz | Lab D | Community |
| 24 May 2026 | Turinabol | 6.6 A | 10mg | 9.1mg | -8.8% | 97.52% | myj1ui | Lab G | Community |
| 23 May 2026 | Proviron (Mesterolone) | 4.3 C | 10mg | 9.5mg | -5.2% | 95.38% | 7urkmg | Lab F | Community |
| 20 May 2026 | AICAR Oral | 8.4 A | 25mg | 22.1mg | -11.5% | 98.19% | bb7qnh | Lab D | Community |
| 20 May 2026 | Enclomiphene | 5.8 B | 10mg | 9.3mg | -7.4% | 96.03% | eh7a2k | Lab C | Public |
| 20 May 2026 | Testosterone Enanthate Raw | 4.0 C | 10g | 11.3g | +12.8% | 95.02% | ni665m | Lab A | Public |
| 19 May 2026 | Methylamine hydrochloride CAS 593-51-1 | 8.3 A | 500g | 461.9g | -7.6% | 97.14% | bzvtbt | Lab C | Community |
| 19 May 2026 | Prostamax | 8.8 A | 15mg | 16.3mg | +8.7% | 97.06% | 75k1ub | Lab D | Public |
| 17 May 2026 | Dianabol | 6.0 A | 50mg | 45.5mg | -9.1% | 99.05% | j4i69s | Lab G | Public |
| 17 May 2026 | KissPeptin-10 | 8.0 A | 2mg | 1.9mg | -4.1% | 99.90% | 5agxsg | Lab A | Public |
| 17 May 2026 | PTD-DBM | 5.5 B | 15mg | 17.7mg | +18.0% | 96.06% | 6elvtu | Lab F | Public |
| 17 May 2026 | Telmisartan | 6.2 A | 25mg | 27.9mg | +11.5% | 96.77% | hqnqp9 | Lab E | Public |
| 26 Jan 2026 | Hexarelin | 5.9 B | 10mg | 10.6mg | +5.9% | 96.51% | mh25sw | Lab C | Public |
| 19 Jan 2026 | Pinealon | 8.0 A | 5mg | 5.0mg | +0.8% | 99.80% | hts2hj | Lab C | Public |
| 7 Jan 2026 | Adipotide | 8.4 A | 50mg | 43.9mg | -12.2% | 96.97% | d9zpvk | Lab G | Community |
| 7 Jan 2026 | EPO | 6.6 A | 30mg | 33.3mg | +11.1% | 97.31% | 8zvvln | Lab E | Community |
| 7 Jan 2026 | Oxymetholone (Anadrol) Raw | 8.5 A | 1g | 1.2g | +23.6% | 97.93% | vghthi | Lab B | Public |
| 7 Jan 2026 | Super Shred | 7.9 A | 200mg/ml | 223.6mg/ml | +11.8% | 96.16% | ryloy0 | Lab C | Community |
| 6 Jan 2026 | Sildenafil Raw | 6.0 A | 500g | 582.5g | +16.5% | 98.36% | oiogfc | Lab E | Public |
| 29 Dec 2025 | Equipoise (Boldenone Undecylenate) | 7.2 A | 100mg/ml | 101.3mg/ml | +1.3% | 96.26% | lde14w | Lab F | Community |
| 29 Dec 2025 | MT-1 | 4.0 C | 15mg | 15.7mg | +5.0% | 97.70% | fq4p8g | Lab E | Public |
| 17 Dec 2025 | Retatrutide | 7.8 A | 20mg | (no batch claim) | 21.1mg | +5.5% | 99.93% | No Label / Silver Crimp / Blue Cap | Lab E |
| 25 Nov 2025 | Retatrutide | 8.0 A | 30mg | (no batch claim) | 29.2mg | -2.7% | 99.95% | No Label / Silver Crimp / Black Cap | Lab E |
| 25 Nov 2025 | Retatrutide | 10.0 A | 10mg | (no batch claim) | 9.96mg | -0.4% | 99.95% | No Label / Silver Crimp / Yellow Cap | Lab E |
| 23 Nov 2025 | Orforglipron | 4.0 C | 25mg | 26.0mg | +3.8% | 98.99% | 0qipsh | Lab F | Public |
| 18 Nov 2025 | Retatrutide | 9.7 A | 30mg | (no batch claim) | 28.6mg | -4.7% | 99.77% | (no data) | Lab E |
| 17 Nov 2025 | Retatrutide | 9.0 A | 10mg | (no batch claim) | 9.85mg | -1.5% | 99.50% | No Label / Silver Crimp / Red Cap | Lab E |
| 17 Nov 2025 | SNAP-8 | 4.0 C | 5mg | 5.1mg | +2.4% | 99.55% | dww4at | Lab G | Public |
| 14 Nov 2025 | Retatrutide | 6.0 B | 10mg | (no batch claim) | 10.9mg | +9.0% | 99.60% | No Label / Silver Crimp / White Cap | Lab G |
| 14 Nov 2025 | KPV Oral | 5.6 B | 100mg | 110.2mg | +10.2% | 98.39% | yo60ix | Lab G | Community |
| 14 Nov 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 5.1 B | 2mg | 2.1mg | +5.6% | 96.45% | g6zjth | Lab A | Public |
| 5 Nov 2025 | Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | 7.1 A | 300mg/ml | 363.9mg/ml | +21.3% | 95.04% | grv6ka | Lab E | Community |
| 9 Oct 2025 | SLU-PP-332 | 4.0 C | 100mg | 112.5mg | +12.5% | 97.55% | cqrzrz | Lab B | Community |
| 3 Oct 2025 | Clomiphene (Clomid) Raw | 6.8 A | 5g | 5.5g | +9.9% | 99.58% | d3mo76 | Lab F | Public |
| 3 Oct 2025 | Trestolone Acetate (MENT) Raw | 5.6 B | 1g | 1.1g | +12.7% | 98.42% | urbg7a | Lab F | Public |
— END OF EVIDENCE LOG —